The Claim
Oral citrulline supplementation has no effect on plasma concentrations of insulin or IGF-1 in adults with short bowel syndrome.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking citrulline by mouth does not change the levels of insulin or IGF-1 in the blood of adults with short bowel syndrome.
See the scientific wording
Oral citrulline supplementation does not affect insulin or IGF-1 plasma concentrations in adults with short bowel syndrome, indicating that its potential metabolic effects are not mediated through these anabolic hormonal pathways.
Citrulline is converted into arginine in the kidneys, which then supports the production of nitric oxide and other molecules that directly stimulate muscle protein building without needing insulin or IGF-1 to signal the process.
What the research says
1 studyThis study gave people with short bowel syndrome citrulline pills and checked their insulin and IGF-1 hormone levels before and after. The levels didn’t change, so citrulline isn’t working through these hormones to affect the body—meaning it must work some other way.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.